Skip to main content
Caplight Logo









Florey Biosciences

Florey Biosciences

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://floreybiosciences.com

Last Round

Pre Seed

Oct 1, 2024

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Florey Biosciences operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Pre Seed round in October 2024.

Florey Biosciences is a biotechnology company developing engineered probiotics as medical food for the dietary management of antibiotic perturbations of the gut microbiome.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Florey Biosciences Comparables

Compare Florey Biosciences with similar companies based on industry and business-model similarity.

Florey Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Theriva Biologics
72%
Unlocked Labs
67%
Seres Therapeutics Inc
61%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Florey Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedOct 1, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Andres Cubillos-Ruiz

Co-founder And Chief Executive Officer

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 8, 2026

    Monthly visitors increased 287% MoM, reaching 201.

  • Jul 27, 2026

    Monthly visitors grew 51% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Florey Biosciences Filings

Explore SEC and related filing metadata, where available.

Florey Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Florey Biosciences's valuation, stock price, and market status.

Is Florey Biosciences a public or private company?

Florey Biosciences is a private company.

What is the current stock price of Florey Biosciences?

Florey Biosciences is a private company, so its shares have no public market price. Caplight tracks Florey Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Florey Biosciences worth (valuation)?

Valuation information for Florey Biosciences is not publicly available.

Can I buy Florey Biosciences stock?

Florey Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Florey Biosciences's last funding round?

Florey Biosciences's most recent funding round was Pre Seed on October 1, 2024.

Who are the main investors in Florey Biosciences?

Investor information for Florey Biosciences is not publicly disclosed.

Will Florey Biosciences IPO soon?

No public IPO plans have been announced for Florey Biosciences.

How can I track Florey Biosciences secondary market activity?

Caplight tracks bids, offers, and trades in Florey Biosciences's shares on secondary markets.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range3
Year Founded2024
Last FundingOct 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?